Drugs / Stop trial intervention for boceprevir, PEG-IFN and RBV
Stop trial intervention for boceprevir, PEG-IFN and RBV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02060058 Background | Nov 2013 → Sep 2016 | chronic hepatitis C virus infection | Kaohsiung Medical University Chung-Ho Memorial Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stop trial intervention for boceprevir, PEG-IFN and RBV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02060058 ↗ |
| Route | Intramuscular | “PegIntron 1.5 mcg/kg im QW” NCT02060058 ↗ |